These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 17570469

  • 21. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE, Holme I, Høye K, Ringertz B.
    Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
    [Abstract] [Full Text] [Related]

  • 22. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B, PreSAP Trial Investigators.
    N Engl J Med; 2006 Aug 31; 355(9):885-95. PubMed ID: 16943401
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
    Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C.
    Singapore Med J; 2006 Jun 31; 47(6):534-42. PubMed ID: 16752024
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial.
    Schumacher HR, Berger MF, Li-Yu J, Perez-Ruiz F, Burgos-Vargas R, Li C.
    J Rheumatol; 2012 Sep 31; 39(9):1859-66. PubMed ID: 22859357
    [Abstract] [Full Text] [Related]

  • 25. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia.
    Farley JH, Truong V, Goo E, Uyehara C, Belnap C, Larsen WI.
    Gynecol Oncol; 2006 Nov 31; 103(2):425-30. PubMed ID: 16677697
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP, VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups.
    J Rheumatol; 2005 Jun 31; 32(6):1093-105. PubMed ID: 15940774
    [Abstract] [Full Text] [Related]

  • 27. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis.
    Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, Feng H, Parsons B.
    Int J Rheum Dis; 2010 May 31; 13(2):151-7. PubMed ID: 20536600
    [Abstract] [Full Text] [Related]

  • 28. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
    Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.
    Clin Cancer Res; 2008 Apr 01; 14(7):2095-101. PubMed ID: 18381950
    [Abstract] [Full Text] [Related]

  • 29. Effects of clarithromycin in patients with active rheumatoid arthritis.
    Ogrendik M.
    Curr Med Res Opin; 2007 Mar 01; 23(3):515-22. PubMed ID: 17355733
    [Abstract] [Full Text] [Related]

  • 30. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
    Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C, IMPACT 2 Study Group.
    Ann Rheum Dis; 2007 Apr 01; 66(4):498-505. PubMed ID: 17114188
    [Abstract] [Full Text] [Related]

  • 31. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
    Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Bowden CL, Soares JC.
    Hum Psychopharmacol; 2008 Mar 01; 23(2):87-94. PubMed ID: 18172906
    [Abstract] [Full Text] [Related]

  • 32. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
    Sinsakul M, Sika M, Rodby R, Middleton J, Shyr Y, Chen H, Han E, Lehrich R, Clyne S, Schulman G, Harris R, Lewis J.
    Am J Kidney Dis; 2007 Dec 01; 50(6):946-51. PubMed ID: 18037095
    [Abstract] [Full Text] [Related]

  • 33. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS, Buvenandran A, Katz B, Kroin JS.
    Anesth Analg; 2008 Apr 01; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
    Genovese MC, Mease PJ, Thomson GT, Kivitz AJ, Perdok RJ, Weinberg MA, Medich J, Sasso EH, M02-570 Study Group.
    J Rheumatol; 2007 May 01; 34(5):1040-50. PubMed ID: 17444593
    [Abstract] [Full Text] [Related]

  • 35. Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study.
    Ekman EF, Wahba M, Ancona F.
    Arthroscopy; 2006 Jun 01; 22(6):635-42. PubMed ID: 16762702
    [Abstract] [Full Text] [Related]

  • 36. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW, Lee EY, Koh EM, Cha HS, Yoo B, Lee CK, Baek HJ, Kim HA, Suh Y, Kang SW, Lee YJ, Jung HG.
    Clin Ther; 2007 May 01; 29(5):862-873. PubMed ID: 17697905
    [Abstract] [Full Text] [Related]

  • 37. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 01; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 38. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1489-98. PubMed ID: 16669964
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group.
    Clin J Pain; 2009 Jun 15; 25(5):376-85. PubMed ID: 19454870
    [Abstract] [Full Text] [Related]

  • 40. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
    Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A, IMPACT 2 Trial Investigators.
    Ann Rheum Dis; 2005 Aug 15; 64(8):1150-7. PubMed ID: 15677701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.